Price $12.61 |
Market Cap
161.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
13.84
|
P/S
11.62
|
Dividend %
-
|
|
P/CF
29.7
|
P/FCF
140.6
|
Op. Cash Flow
1.2K
|
FCF
0.0
|
|
Op. Margin
-3.40%
|
Net Margin
-15.70%
|
ROE
-22.70%
|
ROI
-10.50%
|
|
ROA
-18.80%
|
EPS Growth
71.30%
|
Current Ratio
6.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Allergan plc (AGN) | $173.42 | - | 1.90% | 51.13B | Strong Buy |
| Valeant Pharmaceuticals Intl I (VRX) | $24.27 | - | - | 7.68B | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.05 | - | - | 935.2M | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $6.98 | - | 3.10% | 46.5M | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
